Stocks
Black Diamond Therapeutics (BDTX) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -2.00 | 4.55 | 1.44 | 1.00 | 1.23 | 1.07 | |||
| Changes by years, y/y, % | -134% | -328% | -68% | -31% | +24% | -26.7% | |||
Black Diamond Therapeutics. Debt/EBITDA
Black Diamond Therapeutics. Debt/EBITDA, changes, %
Black Diamond Therapeutics (BDTX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 0.84 | 0.72 | 1.32 | 1.23 | 1.07 | 1.07 | ||
| Changes by years, y/y, % | -103% | -109% | -133% | +23% | +28% | |||
| Changes by quarters, q/q, % | -16% | -14% | +84% | -7% | -13% | |||
